Stanley Riddell, M.D., is a board certified oncologist at SCCA.
Dr. Riddell is an expert at treating lymphoma and myelodysplastic syndrome with bone marrow transplantation. He working to fortify the immune system with better weapons: long-living T-cells specially engineered to seek and destroy cancer.
Dr. Riddell earned his M.D. from the University of Manitoba. Through adoptive T-cell therapy, he and his fellow researchers extract white blood cells from a cancer patient and expose them to proteins made in abundance by tumor cells. Scientists then identify the few T-cells that recognize the tumor proteins and stimulate those to divide, generating a billions-strong population of cancer-fighting cells that can be infused back into the patient. Ideally, this unique population of T-cells will find its way to the tumor site and annihilate the cancer cells.
In his free time Dr. Riddell enjoys cycling, running, theater and parenting.